Christopher A Darlow (Christopher Darlow)

Publication Activity (10 Years)

Years Active: 2013-2024
Publications (10 Years): 20

Top Topics

Urinary Tract Infection

Pseudomonas Aeruginosa

Antimicrobial Resistance

Top Venues

CPT: pharmacometrics & systems pharmacology

The Journal of antimicrobial chemotherapy

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Nicola Farrington, Vineet Dubey, Adam Johnson, Iona Horner, Adam Stevenson, Jennifer Unsworth, Ana Jimenez-Valverde, Julie Schwartz, Shampa Das, William W Hope, Christopher A Darlow
Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by Pseudomonas aeruginosa . mBio 15 (2) (2024)
Nicola Farrington, Vineet Dubey, Adam Johnson, Iona Horner, Adam Stevenson, Jennifer Unsworth, Ana Jimenez-Valverde, Julie Schwartz, Shampa Das, William W Hope, Christopher A Darlow
Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by Pseudomonas aeruginosa . mBio (2024)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Nicola Farrington, Vineet Dubey, Adam Johnson, Iona Horner, Adam Stevenson, Jennifer Unsworth, Ana Jimenez-Valverde, Julie Schwartz, Shampa Das, William W Hope, Christopher A Darlow
Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by Pseudomonas aeruginosa . mBio 15 (2) (2024)
Nicola Farrington, Vineet Dubey, Adam Johnson, Iona Horner, Adam Stevenson, Jennifer Unsworth, Ana Jimenez-Valverde, Julie Schwartz, Shampa Das, William W Hope, Christopher A Darlow
Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by Pseudomonas aeruginosa . mBio 15 (2) (2024)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology (2023)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology (2023)
Christopher A Darlow, William Hope
Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales. The Journal of antimicrobial chemotherapy 77 (3) (2022)
Christopher A Darlow, Laura McEntee, Adam Johnson, Nicola Farrington, Jennifer Unsworth, Ana Jimenez-Valverde, Bhavana Jagota, Ruwanthi Kolamunnage-Dona, Renata M A Da Costa, Sally Ellis, François Franceschi, Mike Sharland, Michael Neely, Laura J V Piddock, Shampa Das, William Hope
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings. The Journal of antimicrobial chemotherapy 77 (12) (2022)
Nicola Farrington, Laura McEntee, Adam Johnson, Jennifer Unsworth, Christopher A Darlow, Ana Jimenez-Valverde, Christoph Hornik, Rachel Greenberg, Julie Schwartz, Shampa Das, William W Hope
Pharmacodynamics of Meropenem and Tobramycin for Neonatal Meningoencephalitis: Novel Approaches to Facilitate the Development of New Agents to Address the Challenge of Antimicrobial Resistance. Antimicrobial agents and chemotherapy 66 (4) (2022)
Christopher A Darlow, Nicola Farrington, Adam Johnson, Laura McEntee, Jennifer Unsworth, Ana Jimenez-Valverde, Ruwanthi Kolamunnage-Dona, Renata M A Da Costa, Sally Ellis, François Franceschi, Mike Sharland, Michael Neely, Laura J V Piddock, Shampa Das, William Hope
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance. The Journal of antimicrobial chemotherapy 77 (5) (2022)
Christopher A Darlow, William Hope
Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales-authors' response. The Journal of antimicrobial chemotherapy 77 (7) (2022)
Christopher A Darlow, Renata M A da Costa, Sally Ellis, François Franceschi, Mike Sharland, Laura Piddock, Shampa Das, William Hope
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria. Paediatric drugs 23 (5) (2021)
Christopher A Darlow, Nikolaos Paidakakos, Murtuza Sikander, Bridget Atkins
A spinal infection with Staphylococcus pseudintermedius. BMJ case reports 2017 (2017)
Christopher A Darlow, Peter Tovey, Fiona Wallis, Clare Knowles, Ian Fairley, Charles Lacey, Fabiola Martin
Remembering the Children: Implementation and Success of a Robust Method for Identifying and Testing Children of HIV Patients. Journal of sexually transmitted diseases 2013 (2013)